Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

BackgroundAs SARS-CoV-2 will likely continue to circulate, low-impact methods become more relevant to monitor antibody-mediated immunity. Saliva sampling could provide a non-invasive method with reduced impact on children. Studies reporting on the differences between systemic and mucosal humoral imm...

Full description

Bibliographic Details
Main Authors: Maya W. Keuning, Marloes Grobben, Merijn W. Bijlsma, Beau Anker, Eveline P. Berman-de Jong, Sophie Cohen, Mariet Felderhof, Anne-Elise de Groen, Femke de Groof, Maarten Rijpert, Hetty W. M. van Eijk, Khadija Tejjani, Jacqueline van Rijswijk, Maurice Steenhuis, Theo Rispens, Frans B. Plötz, Marit J. van Gils, Dasja Pajkrt
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
mucosal antibody response
mucosal IgG
antibody prevalence
children
saliva antibodies
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.976382/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.976382/full

Similar Items